Kamal Therapeutics, Inc. funding

Kamal Therapeutics, Inc., a pharmaceuticals company based in Hingham, MA (founded 2020), filed a Form D with the SEC on November 24, 2025 and reported $13.8M raised of a $17.3M offering.

Amount raised$13.8M

Offering size$17.3M

Filed with the SECNovember 24, 2025

First saleNovember 10, 2025

IndustryPharmaceuticals

SecuritiesEquity

LocationHingham, MA

Founded2020

Entity typeCorporation

Investors so far41

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 24

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care